A Rare Case of Ixazomib-Induced Cutaneous Necrotizing Vasculitis in a Patient with Relapsed Myeloma
Joint Authors
Shenouda, Mina
Lebowicz, Yehuda
Katz, Heather
Dahshan, Deena
Sonnier, George
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-10-20
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Ixazomib is the only oral proteasome inhibitor used in relapsed/refractory myeloma.
Cutaneous side effects due to ixazomib have been documented in the literature; however, cutaneous necrotizing vasculitis is extremely rare.
We describe a case of a 74-year-old man with relapsed multiple myeloma who was started on ixazomib, lenalidomide, and dexamethasone.
He developed several skin lesions that were biopsied and revealed cutaneous necrotizing vasculitis.
Ixazomib was held with resolution of the vasculitic lesions and restarted with dexamethasone to 20 mg on the day of treatment and 20 mg dose the day after treatment.
American Psychological Association (APA)
Katz, Heather& Shenouda, Mina& Dahshan, Deena& Sonnier, George& Lebowicz, Yehuda. 2019. A Rare Case of Ixazomib-Induced Cutaneous Necrotizing Vasculitis in a Patient with Relapsed Myeloma. Case Reports in Hematology،Vol. 2019, no. 2019, pp.1-4.
https://search.emarefa.net/detail/BIM-1136645
Modern Language Association (MLA)
Katz, Heather…[et al.]. A Rare Case of Ixazomib-Induced Cutaneous Necrotizing Vasculitis in a Patient with Relapsed Myeloma. Case Reports in Hematology No. 2019 (2019), pp.1-4.
https://search.emarefa.net/detail/BIM-1136645
American Medical Association (AMA)
Katz, Heather& Shenouda, Mina& Dahshan, Deena& Sonnier, George& Lebowicz, Yehuda. A Rare Case of Ixazomib-Induced Cutaneous Necrotizing Vasculitis in a Patient with Relapsed Myeloma. Case Reports in Hematology. 2019. Vol. 2019, no. 2019, pp.1-4.
https://search.emarefa.net/detail/BIM-1136645
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1136645
